These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22158481)

  • 21. Impact of screening colonoscopy on outcomes in colorectal cancer.
    Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
    Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
    Graser A; Melzer A; Lindner E; Nagel D; Herrmann K; Stieber P; Schirra J; Mansmann U; Reiser MF; Göke B; Kolligs FT
    Gastroenterology; 2013 Apr; 144(4):743-750.e2. PubMed ID: 23415805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.
    Rodríguez-Moranta F; Trapero-Bertran M; Castells A; Mas-Canal X; Balaguer F; Pellisé M; Gonzalo V; Ocaña T; Trilla A; Piqué JM
    Gastroenterol Hepatol; 2008; 31(7):405-12. PubMed ID: 18783684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for colorectal cancer in Italy: 2007 survey.
    Zorzi M; Fedato C; Naldoni C; Sassatelli R; Sassoli De' Bianchi P; Senore C; Visioli CB; Cogo C
    Epidemiol Prev; 2009; 33(3 Suppl 2):57-74. PubMed ID: 19776487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.
    Segnan N; Senore C; Andreoni B; Aste H; Bonelli L; Crosta C; Ferraris R; Gasperoni S; Penna A; Risio M; Rossini FP; Sciallero S; Zappa M; Atkin WS;
    J Natl Cancer Inst; 2002 Dec; 94(23):1763-72. PubMed ID: 12464648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community.
    Crotta S; Castiglione G; Grazzini G; Valle F; Mosconi S; Rosset R
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):33-7. PubMed ID: 15095850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
    Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
    Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
    O'Leary BA; Olynyk JK; Neville AM; Platell CF
    J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for colorectal cancer in Italy: 2004 survey.
    Zorzi M; Grazzini G; Senore C; Vettorazzi M
    Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for colorectal cancer in Italy: 2006 survey.
    Zorzi M; Falcini F; Fedato C; Grazzini G; de' Bianchi PS; Senore C; Vettorazzi M; Visioli C; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):55-68. PubMed ID: 18770995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial: Flexible sigmoidoscopy as an adjunct to faecal occult blood testing in population screening.
    Steele RJ; Carey FA; Stanners G; Lang J; Brand J; Brownlee LA; Crichton EM; Winter JW; Phull PS; Mowat C; Strachan JA; Digan AM; Fraser CG
    J Med Screen; 2020 Jun; 27(2):59-67. PubMed ID: 31690179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
    Holme Ø; Løberg M; Kalager M; Bretthauer M; Hernán MA; Aas E; Eide TJ; Skovlund E; Schneede J; Tveit KM; Hoff G
    JAMA; 2014 Aug; 312(6):606-15. PubMed ID: 25117129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
    Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
    Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between use of low-dose aspirin and detection of colorectal polyps and cancer in a screening setting.
    Nafisi S; Randel KR; Støer NC; Veierød MB; Hoff G; Holme Ø; Schult AL; Botteri E
    Dig Liver Dis; 2023 Aug; 55(8):1126-1132. PubMed ID: 36754644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of screening for colorectal cancer.
    Garborg K; Holme Ø; Løberg M; Kalager M; Adami HO; Bretthauer M
    Ann Oncol; 2013 Aug; 24(8):1963-72. PubMed ID: 23619033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.